{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:20:29Z","timestamp":1775467229628,"version":"3.50.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.706","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T07:48:06Z","timestamp":1123487286000},"page":"706-709","source":"Crossref","is-referenced-by-count":38,"title":["Frequency of Gouty Arthritis in Patients with End-stage Renal Disease in Japan"],"prefix":"10.2169","volume":"44","author":[{"given":"Iwao","family":"OHNO","sequence":"first","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyoshi","family":"ICHIDA","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"OKABE","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"HIKITA","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijiro","family":"UETAKE","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"KIMURA","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"SAIKAWA","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"HOSOYA","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol 282<\/b>: F991-F997, 2002.","DOI":"10.1152\/ajprenal.00283.2001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sanchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol 283<\/b>: F1105-F1110, 2002.","DOI":"10.1152\/ajprenal.00170.2002"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000034910.58454.FD"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nakagawa T, Mazzali M, Kang DH, et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 23<\/b>: 2-7, 2003.","DOI":"10.1159\/000066303"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87<\/b>: 333-339, 2001.","DOI":"10.1159\/000045939"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia: A long-term population study. Am J Med 42<\/b>: 27-37, 1967.","DOI":"10.1016\/0002-9343(67)90004-6"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.266.21.3004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incident of gout. The role of hypertension. Arthritis Rheum 38<\/b>: 628-632, 1995.","DOI":"10.1002\/art.1780380508"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ifudu O, Tan CC, Dulin AL, Delano BG, Friedman EA. Gouty arthritis in end-stage renal disease: Clinical course and rarity of new cases. Am J Kidney Dis 23<\/b>: 347-351, 1994.","DOI":"10.1016\/S0272-6386(12)80995-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakai S, Niisato T, Nagura Y, et al. The present state of chronic dialysis therapy in Japan. J Jpn Soc Dial Ther 37<\/b>: 1-24, 2004 (in Japanese).","DOI":"10.4009\/jsdt.37.1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20<\/b>: 895-900, 1977.","DOI":"10.1002\/art.1780200320"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Schreiner O, Wandel E, Himmelsbach F, Galle PR, Marker-Hermann E. Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients? Nephrol Dial Transplant 15<\/b>: 644-649, 2000.","DOI":"10.1093\/ndt\/15.5.644"},{"key":"13","unstructured":"13) Gomi M, Mineo I, Nakagawa C, Nogami A, Tarui S. Association of hyperuricemia with glucose intolerance and diabetes mellitus. Hyperuricemia and Gout 7<\/b>: 119-124, 1999 (in Japanese)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nishioka N, Mikanagi K. Clinical features of 4,000 gouty subjects in Japan. Adv Exp Med Biol 122A<\/b>: 47-54, 1980.","DOI":"10.1007\/978-1-4615-9140-5_8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Simmonds HA, Cameron JS, Morris GS, Davies PM. Allopurinol in renal failure and the tumor lysis syndrome. Clin Chim Acta 160<\/b>: 189-195, 1986.","DOI":"10.1016\/0009-8981(86)90141-5"},{"issue":"1","key":"16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.HYP.34.1.144","volume":"34","author":"ALDERMAN M H","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relationship between serum uric acid and risk of cardiovascular disease in essential hypertension: The PIUMA study. Hypertension 36<\/b>: 1072-1078, 2000.","DOI":"10.1161\/01.HYP.36.6.1072"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang J, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37<\/b>: 1069-1074, 2001.","DOI":"10.1161\/01.HYP.37.4.1069"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/7\/44_7_706\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:24:18Z","timestamp":1621445058000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/7\/44_7_706\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.706","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}